甘胺酸市场：型态、类型和应用划分 - 2024-2030 年全球预测

预计2023年甘胺酸市场规模为15.3亿美元，预计2024年将达16.2亿美元，2030年将达到22.5亿美元，复合年增长率为5.58%。甘氨酸盐，通常称为甘氨酸螯合物，是透过甘氨酸（一种氨基酸）与金属离子结合的螯合过程产生的。甘氨酸盐市场包括甘氨酸盐的生产和销售，甘氨酸盐是一种螯合矿物质，通常用作营养和製药应用的添加剂。消费者健康意识的提高、对矿物质强化营养补充的需求增加食品甘氨酸在动物饲料领域的应用不断扩大正在推动市场成长。原材料价格的波动、替代产品的可用性以及与甘氨酸相关的副作用可能会限制市场开拓。新型甘胺酸製剂的创新将为市场拓展提供新的可能性。此外，甘胺酸循环製程在沼气升级的新兴应用预计将创造市场成长机会。主要市场统计基准年[2023]15.3亿美元预测年份[2024]16.2亿美元预测年份[2030]22.5亿美元复合年增长率（%）5.58%干燥的甘氨酸盐型态在各种环境条件下都很稳定，从而增加了其多功能性。干甘氨酸盐是甘氨酸盐的固态形式，常用于製药、个人护理和营养领域。当很重要的保质期或需要精确剂量时是首选。当考虑稳定性时，也优选干法，因为它们比液体更不易劣化。液体甘氨酸盐是水溶液或悬浮液，主要用于易于整合到液体配方中，例如饮料和液体补充品。这种型态通常被选用于需要快速吸收或干燥型态存在溶解度问题的应用。甘氨酸镁的需求量不断增加，因为它以放鬆肌肉和缓解压力而闻名。甘氨酸钙是一种流行的螯合矿物质补充品，主要用于促进钙的吸收和支持骨骼健康。它比含有碳酸钙的传统钙补充品具有更高的生物有效性，使其成为胃酸低和寻求更有效吸收的人的首选。甘氨酸铜用作营养补充和饲料添加剂，提供酶过程和维持健康的免疫系统所需的必需微量元素。甘氨酸铜对于铜缺乏症和动物饲料强化至关重要。甘氨酸镁以其优异的吸收率和健胃作用而闻名，可以帮助放鬆肌肉、减轻压力、提高睡眠品质。甘氨酸锰在人类和动物饮食中用作营养成分，有助于各种代谢过程和结缔组织的形成。甘氨酸钠主要用于个人护理行业，在各种护肤产品中充当皮肤调理剂和缓衝剂。甘氨酸钠因其温和和舒缓皮肤的特性而被化妆品配方设计师用于针对敏感肌肤的产品中。甘氨酸锌因其在支持免疫系统、皮肤健康和蛋白质合成方面的重要作用而被选中。其优异的生物利用度使其成为首选的锌补充品。甘氨酸作为刺激性化学物质的替代品在个人保健产品中的潜力不断增长甘氨酸作为饲料添加剂，由于其高生物利用度，主要用作动物营养中的矿物质补充品。这些螯合化合物可改善动物的矿物质状况，进而促进生长、生产力和整体健康。常见类型包括甘氨酸镁、锌、铜和甘氨酸锰。基于需求的偏好着重于提高牲畜品质和产量，甘胺酸比非螯合矿物质更受青睐，因为甘胺酸具有更好的吸收性和更低的环境影响。甘氨酸用于促进快速生长和骨骼发育。在食品工业中，甘氨酸盐被用作添加剂，以丰富食品和饮料的必需矿物质。甘胺酸的生物利用度可改善乳製品、谷类和婴儿奶粉奶粉等产品的营养状况。消费者对机能性食品的偏好不断增加，对甘胺酸作为食品添加物的需求也随之增加。甘氨酸盐非常安全，是保持食品味道和稳定性的首选。由于其亲肤特性，甘胺酸在个人保健产品中有着重要的应用。用于香皂、洗髮精、护肤品等配方中，提供温和、温和的清洗效果并稳定泡沫。在製药和营养补充食品，甘胺酸盐被用作食品营养补充的关键成分，以增强矿物质供应并支持整体健康。区域洞察美国因其先进的农业技术和饲料工业，广泛使用甘胺酸作为添加剂，是甘胺酸的主要消费国之一。大型个人护理和製药公司的存在也导致了对甘氨酸的巨大需求，以改进产品配方。南美洲拥有大量的牲畜种群和庞大的农业部门，因此甘氨酸的使用机会很多。亚太地区（APAC）甘胺酸市场成长迅速，其中中国和印度是主要贡献者。这种扩张是由于该地区肉类消费的增加、健康意识的增强以及个人护理行业的快速增长。此外，该地区庞大的农业部门为甘胺酸的应用提供了充足的机会，以提高作物产量和土壤健康。欧洲国家对饲料添加剂和个人护理成分有严格的规定，这导致采用更高品质的甘胺酸盐。完善的医疗保健系统的存在以及消费者对健康和营养意识的提高正在推动欧洲市场的扩张。中东和非洲市场仍然是一个新兴市场，经济多元化的努力和个人保健产品供应的增加影响着潜力。FPNV定位矩阵FPNV定位矩阵对于评估甘胺酸市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。市场占有率分析市场占有率分析是一种综合工具，可以对甘胺酸市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。本报告在以下方面提供了宝贵的见解：1.市场渗透率：提供有关主要企业所服务的市场的全面资讯。2.市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。3.市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。4.竞争评估及资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行综合评估。5.产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。本报告解决了以下关键问题：更多详情，请W:chenyu-zl，获取报告样品和报价汽车行业分析专家，8年汽车行业研究经验，逻辑性强，数据敏感度较高。合作伙伴：道依茨、采埃孚、大陆集团、三菱重工、沃尔沃、米其林等。1.甘胺酸市场的市场规模和预测是多少？2.甘胺酸市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些？3.甘胺酸市场的技术趋势和法规结构是什么？4.甘胺酸市场主要供应商的市场占有率是多少？5.进入甘胺酸市场适合的型态和策略手段是什么？目录第一章前言第二章调查方法第三章执行摘要第四章市场概况第五章市场洞察市场动态促进因素消费者健康意识的提高和对矿物质强化营养补充食品的需求不断增加扩大甘胺酸在动物饲料领域的应用抑制因素原物料价格波动机会新型甘胺酸盐配方的创新甘胺酸循环製程在沼气提质的新应用任务替代产品的可用性以及与甘胺酸相关的副作用市场区隔分析型态:扩大使用干燥甘氨酸盐以在各种环境条件下提供稳定性类型：甘氨酸镁由于其具有放鬆肌肉和减轻压力的声誉而受到很高的需求。应用：扩大甘氨酸在个人保健产品中作为更刺激化学替代品的潜力市场扰动分析波特五力分析价值炼和关键路径分析价格分析技术分析专利分析贸易分析法规结构分析第六章甘胺酸市场：型态干燥液体第七章甘胺酸市场：依类型甘氨酸钙甘氨酸铜甘胺酸镁甘氨酸锰甘氨酸钠甘氨酸锌第八章甘胺酸市场：依应用分类饲料添加剂食品添加物个人保健产品药品和营养补充食品第九章美洲甘氨酸市场阿根廷巴西加拿大墨西哥美国第10章亚太甘氨酸市场澳洲中国印度印尼日本马来西亚菲律宾新加坡韩国台湾泰国越南第十一章欧洲、中东和非洲甘胺酸市场丹麦埃及芬兰法国德国以色列义大利荷兰奈及利亚挪威波兰卡达俄罗斯沙乌地阿拉伯南非西班牙瑞典瑞士土耳其阿拉伯聯合大公国英国第十二章竞争格局2023年市场占有率分析FPNV定位矩阵，2023竞争情境分析TraceMinerals在酵母天然品博览会上推出七种新产品PlanetOrganic推出自有品牌补充品系列战略分析和建议第13章竞争产品组合主要企业简介主要产品系列简介目录图表ProductCode:MRR-43539E5D2BD6[185PagesReport]TheGlycinatesMarketsizewasestimatedatUSD1.53billionin2023andexpectedtoreachUSD1.62billionin2024,ataCAGR5.58%toreachUSD2.25billionby2030.Glycinates,commonlyknownasglycinechelates,areproducedthroughachelationprocessthatinvolvesthebondingofglycine,anaminoacid,withmetalions.Theglycinatesmarketcomprisestheproductionandsaleofglycinates,achelatedmineraloftenusedasanadditiveinnutritionalandpharmaceuticalapplications.Risinghealthconsciousnessamongconsumers,theincreasingdemandformineral-enricheddietarysupplements,andthegrowingapplicationofglycinatesintheanimalfeedsectorfostermarketgrowth.Fluctuatingrawmaterialprices,availabilityofsubstituteproducts,andadverseeffectsassociatedwithglycinatescanlimitmarketdevelopment.Innovationsinnewglycinate-basedformulationswilllikelypresentnewpossibilitiesformarketexpansion.Inaddition,emergingapplicationsofglycinate-loopingprocessesforbiogasupgradingareexpectedtocreategrowthopportunitiesinthemarket.KEYMARKETSTATISTICSBaseYear[2023]USD1.53billionEstimatedYear[2024]USD1.62billionForecastYear[2030]USD2.25billionCAGR(%)5.58%Form:ExpandingusageofdryglycinatesasitprovidesstabilityinvariousenvironmentalconditionsDryglycinatesarethesolidformofglycinates,whicharecommonlyusedinthepharmaceutical,personalcare,andnutritionalsectors.Theyarepreferredwhenthelongevityoftheshelflifeisvitalandwhenprecisedosingisrequired.Thedryformisalsofavoredwhenstabilityisaconcern,asitislesspronetodegradationthanliquidforms.Liquidglycinatesareaqueoussolutionsorsuspensionsthatareprimarilyutilizedfortheireaseofintegrationintoliquid-basedformulationssuchasbeveragesandliquidsupplements.Thisformisoftenchosenforapplicationswhererapidabsorptionisdesirableorwhentherearesolubilitychallengeswiththedryform.Type:IncreasingdemandformagnesiumglycinateduetoitsrenownedinmusclerelaxationandstressreductionCalciumglycinateisapopularchelatedmineralsupplementusedprimarilyforenhancingcalciumuptakeandsupportingbonehealth.Itshighbioavailabilitycomparedtotraditionalcalciumsupplements,includingcalciumcarbonate,makesitapreferredchoiceforindividualswithlowstomachacidorthoseseekingmoreefficientabsorption.Copperglycinateisusedasadietarysupplementandfeedadditive,providinganessentialtraceelementneededforenzymaticprocessesandthemaintenanceofimmunesystemhealth.Copperglycinateisessentialforindividualsdealingwithcopperdeficienciesandforenhancinganimalfeednutritionalquality.Magnesiumglycinateisrenownedforitsrolesinmusclerelaxation,stressreduction,andimprovingsleepquality,owingtoitsexcellentabsorptionratesandgentleeffectonthestomach.Manganeseglycinateisutilizedasanutritionalcomponentbothinhumanandanimaldiets,assistinginvariousmetabolicprocessesandtheformationofconnectivetissue.Primarilyusedinthepersonalcareindustry,sodiumglycinateactsasaskinconditioningagentandbufferingagentinvariousskincareproducts.Sodiumglycinateisutilizedbycosmeticformulatorsforproductstargetingsensitiveskinduetoitsmildnatureandskin-soothingproperties.Zincglycinateischosenforitspivotalroleinsupportingtheimmunesystem,skinhealth,andproteinsynthesis.Itsexcellentbioavailabilitymakesitafavorablezincsupplementform.Application:GrowingpotentialofglycinatesinpersonalcareproductsasanalternativetoharsherchemicalsGlycinatesasfeedadditivesareprimarilyutilizedfortheirhighbioavailabilityasmineralsupplementsinanimalnutrition.Thesechelatedcompoundsimprovethemineralstatusofanimals,leadingtoenhancedgrowth,productivity,andoverallhealth.Commontypesincludemagnesium,zinc,copper,andmanganeseglycinate.Withtheneed-basedpreferencefocusingonimprovinglivestockqualityandyield,glycinatesarepreferredovernon-chelatedmineralsduetotheirbetterabsorptionratesandlowerenvironmentalimpact.Thedemandisparticularlyhighinpoultryandswineapplications,whereglycinatesareusedtofosterquickergrowthandbonedevelopment.Inthefoodindustry,glycinatesareusedasadditivestofortifyfoodsandbeverageswithessentialminerals.Thebioavailabilityofglycinatesenhancesthenutritionalprofileofproducts,includingdairy,cereals,andinfantformula.Consumers'increasingpreferenceforfunctionalfoodsdrivestheneedforglycinatesasafoodadditive.Theyareconsideredsafeandarefavoredformaintainingthetasteandstabilityofthefoodproducts.Glycinatesfindsignificantapplicationsinpersonalcareproductsduetotheirskin-friendlyproperties.Theyareusedinformulationsforsoaps,shampoos,andskincareproductstoofferamildandgentlecleansingeffectandtostabilizefoam.Inthepharmaceutical&nutraceuticalindustry,glycinatesareusedasakeycomponentindietarysupplementstoenhancemineraldeliveryandsupportoverallhealthandwellness.RegionalInsightsTheUnitedStatesisamongthemajorconsumersofglycinatesduetoitsadvancedagriculturaltechnologyandsubstantialfeedindustry,whichextensivelyusesglycinatesasadditives.Thepresenceofleadingpersonalcareandpharmaceuticalcompaniesalsocontributestosignificantglycinatesdemandforimprovedproductformulations.AcrossSouthAmerica,theprominentlivestockpopulationandlargeagriculturesectorprovideconsiderableopportunitiesfortheuseofglycinates.TheAsia-Pacific(APAC)iswitnessingrapidgrowthintheglycinatesmarket,withChinaandIndiabeingthemajorcontributors.Theexpansionisattributedtorisingmeatconsumption,growinghealthconsciousness,andtheburgeoningpersonalcareindustryintheregion.Additionally,theregion'slargeagriculturalsectorprovidesampleopportunitiesforglycinateapplicationinenhancingcropyieldsandsoilhealth.Europeancountrieshavestringentregulationsregardingfeedadditivesandpersonalcareingredients,whichhasledtotheadoptionofhigh-qualityglycinates.Thepresenceofwell-establishedhealthcaresystemsandgrowingconsumerawarenessabouthealthandnutritionaidtheEuropeanmarket'sexpansion.TheMiddleEasternandAfricanmarketsarestilldeveloping,withthepotentialinfluencedbyeconomicdiversificationeffortsandtheincreasingavailabilityofpersonalcareproducts.FPNVPositioningMatrixTheFPNVPositioningMatrixispivotalinevaluatingtheGlycinatesMarket.Itoffersacomprehensiveassessmentofvendors,examiningkeymetricsrelatedtoBusinessStrategyandProductSatisfaction.Thisin-depthanalysisempowersuserstomakewell-informeddecisionsalignedwiththeirrequirements.Basedontheevaluation,thevendorsarethencategorizedintofourdistinctquadrantsrepresentingvaryinglevelsofsuccess:Forefront(F),Pathfinder(P),Niche(N),orVital(V).MarketShareAnalysisTheMarketShareAnalysisisacomprehensivetoolthatprovidesaninsightfulandin-depthexaminationofthecurrentstateofvendorsintheGlycinatesMarket.Bymeticulouslycomparingandanalyzingvendorcontributionsintermsofoverallrevenue,customerbase,andotherkeymetrics,wecanoffercompaniesagreaterunderstandingoftheirperformanceandthechallengestheyfacewhencompetingformarketshare.Additionally,thisanalysisprovidesvaluableinsightsintothecompetitivenatureofthesector,includingfactorssuchasaccumulation,fragmentationdominance,andamalgamationtraitsobservedoverthebaseyearperiodstudied.Withthisexpandedlevelofdetail,vendorscanmakemoreinformeddecisionsanddeviseeffectivestrategiestogainacompetitiveedgeinthemarket.KeyCompanyProfilesThereportdelvesintorecentsignificantdevelopmentsintheGlycinatesMarket,highlightingleadingvendorsandtheirinnovativeprofiles.TheseincludeABEnterprises,AdityaChemicals,AjinomotoCo.,Inc.,BalchemInc.,BASFSE,ChaitanyaBiologicalsPvt.Ltd,ClariantAG,ColonialChemicalInc.,GalaxySurfactantsLimited,Innospec,JHBiotechInc.,JostChemicalCo.,NovotechNutraceuticals,Inc.,PatImpexPrivateLimited,PHARMAVITApS,ShijiazhuangDonghuaJinlongChemicalIndustryCo.,Ltd.,SinoLionUSA,SolvayS.A.,SuchemIndustries,SurfaceChemicalIndustryCo.Ltd.,andUNOVETCHEM.MarketSegmentation&CoverageThisresearchreportcategorizestheGlycinatesMarkettoforecasttherevenuesandanalyzetrendsineachofthefollowingsub-markets:FormDryLiquidTypeCalciumGlycinateCopperGlycinateMagnesiumGlycinateManganeseGlycinateSodiumGlycinateZincGlycinateApplicationFeedAdditivesFoodAdditivesPersonalCareProductsPharmaceuticals&NutraceuticalsRegionAmericasArgentinaBrazilCanadaMexicoUnitedStatesCaliforniaFloridaIllinoisNewYorkOhioPennsylvaniaTexasAsia-PacificAustraliaChinaIndiaIndonesiaJapanMalaysiaPhilippinesSingaporeSouthKoreaTaiwanThailandVietnamEurope,MiddleEast&AfricaDenmarkEgyptFinlandFranceGermanyIsraelItalyNetherlandsNigeriaNorwayPolandQatarRussiaSaudiArabiaSouthAfricaSpainSwedenSwitzerlandTurkeyUnitedArabEmiratesUnitedKingdomThereportoffersvaluableinsightsonthefollowingaspects:1.MarketPenetration:Itpresentscomprehensiveinformationonthemarketprovidedbykeyplayers.2.MarketDevelopment:Itdelvesdeepintolucrativeemergingmarketsandanalyzesthepenetrationacrossmaturemarketsegments.3.MarketDiversification:Itprovidesdetailedinformationonnewproductlaunches,untappedgeographicregions,recentdevelopments,andinvestments.4.CompetitiveAssessment&Intelligence:Itconductsanexhaustiveassessmentofmarketshares,strategies,products,certifications,regulatoryapprovals,patentlandscape,andmanufacturingcapabilitiesoftheleadingplayers.5.ProductDevelopment&Innovation:Itoffersintelligentinsightsonfuturetechnologies,R&Dactivities,andbreakthroughproductdevelopments.Thereportaddresseskeyquestionssuchas:1.WhatisthemarketsizeandforecastoftheGlycinatesMarket?2.Whichproducts,segments,applications,andareasshouldoneconsiderinvestinginovertheforecastperiodintheGlycinatesMarket?3.WhatarethetechnologytrendsandregulatoryframeworksintheGlycinatesMarket?4.WhatisthemarketshareoftheleadingvendorsintheGlycinatesMarket?5.WhichmodesandstrategicmovesaresuitableforenteringtheGlycinatesMarket?TableofContents1.Preface1.1.ObjectivesoftheStudy1.2.MarketSegmentation&Coverage1.3.YearsConsideredfortheStudy1.4.Currency&Pricing1.5.Language1.6.Stakeholders2.ResearchMethodology2.1.Define:ResearchObjective2.2.Determine:ResearchDesign2.3.Prepare:ResearchInstrument2.4.Collect:DataSource2.5.Analyze:DataInterpretation2.6.Formulate:DataVerification2.7.Publish:ResearchReport2.8.Repeat:ReportUpdate3.ExecutiveSummary4.MarketOverview5.MarketInsights5.1.MarketDynamics5.1.1.Drivers.Risinghealthconsciousnessamongconsumersandtheincreasingdemandformineral-enricheddietarysupplements.Growingapplicationofglycinatesintheanimalfeedsector5.1.2.Restraints.Fluctuatingrawmaterialprices5.1.3.Opportunities.Innovationsinnewglycinate-basedformulations.Emergingapplicationsofglycinate-loopingprocessesforbiogasupgrading5.1.4.Challenges.Availabilityofsubstituteproductsandadverseeffectsassociatedwithglycinates5.2.MarketSegmentationAnalysis5.2.1.Form:Expandingusageofdryglycinatesasitprovidesstabilityinvariousenvironmentalconditions5.2.2.Type:Increasingdemandformagnesiumglycinateduetoitsrenownedinmusclerelaxationandstressreduction5.2.3.Application:Growingpotentialofglycinatesinpersonalcareproductsasanalternativetoharsherchemicals5.3.MarketDisruptionAnalysis5.4.Porter'sFiveForcesAnalysis5.4.1.ThreatofNewEntrants5.4.2.ThreatofSubstitutes5.4.3.BargainingPowerofCustomers5.4.4.BargainingPowerofSuppliers5.4.5.IndustryRivalry5.5.ValueChain&CriticalPathAnalysis5.6.PricingAnalysis5.7.TechnologyAnalysis5.8.PatentAnalysis5.9.TradeAnalysis5.10.RegulatoryFrameworkAnalysis6.GlycinatesMarket,byForm6.1.Introduction6.2.Dry6.3.Liquid7.GlycinatesMarket,byType7.1.Introduction7.2.CalciumGlycinate7.3.CopperGlycinate7.4.MagnesiumGlycinate7.5.ManganeseGlycinate7.6.SodiumGlycinate7.7.ZincGlycinate8.GlycinatesMarket,byApplication8.1.Introduction8.2.FeedAdditives8.3.FoodAdditives8.4.PersonalCareProducts8.5.Pharmaceuticals&Nutraceuticals9.AmericasGlycinatesMarket9.1.Introduction9.2.Argentina9.3.Brazil9.4.Canada9.5.Mexico9.6.UnitedStates10.Asia-PacificGlycinatesMarket10.1.Introduction10.2.Australia10.3.China10.4.India10.5.Indonesia10.6.Japan10.7.Malaysia10.8.Philippines10.9.Singapore10.10.SouthKorea10.11.Taiwan10.12.Thailand10.13.Vietnam11.Europe,MiddleEast&AfricaGlycinatesMarket11.1.Introduction11.2.Denmark11.3.Egypt11.4.Finland11.5.France11.6.Germany11.7.Israel11.8.Italy11.9.Netherlands11.10.Nigeria11.11.Norway11.12.Poland11.13.Qatar11.14.Russia11.15.SaudiArabia11.16.SouthAfrica11.17.Spain11.18.Sweden11.19.Switzerland11.20.Turkey11.21.UnitedArabEmirates11.22.UnitedKingdom12.CompetitiveLandscape12.1.MarketShareAnalysis,202312.2.FPNVPositioningMatrix,202312.3.CompetitiveScenarioAnalysis12.3.1.TraceMineralstoDebutSevenNewProductsatNaturalProductsExpoEast12.3.2.PlanetOrganicLaunchesOwn-BrandSupplementsLine12.4.StrategyAnalysis&Recommendation13.CompetitivePortfolio13.1.KeyCompanyProfiles13.2.KeyProductPortfolio简介目录图表LISTOFFIGURESFIGURE1.GLYCINATESMARKETRESEARCHPROCESSFIGURE2.GLYCINATESMARKETSIZE,2023VS2030FIGURE3.GLOBALGLYCINATESMARKETSIZE,2018-2030(USDMILLION)FIGURE4.GLOBALGLYCINATESMARKETSIZE,BYREGION,2023VS2030(%)FIGURE5.GLOBALGLYCINATESMARKETSIZE,BYREGION,2023VS2024VS2030(USDMILLION)FIGURE6.GLYCINATESMARKETDYNAMICSFIGURE7.GLOBALGLYCINATESMARKETSIZE,BYFORM,2023VS2030(%)FIGURE8.GLOBALGLYCINATESMARKETSIZE,BYFORM,2023VS2024VS2030(USDMILLION)FIGURE9.GLOBALGLYCINATESMARKETSIZE,BYTYPE,2023VS2030(%)FIGURE10.GLOBALGLYCINATESMARKETSIZE,BYTYPE,2023VS2024VS2030(USDMILLION)FIGURE11.GLOBALGLYCINATESMARKETSIZE,BYAPPLICATION,2023VS2030(%)FIGURE12.GLOBALGLYCINATESMARKETSIZE,BYAPPLICATION,2023VS2024VS2030(USDMILLION)FIGURE13.AMERICASGLYCINATESMARKETSIZE,BYCOUNTRY,2023VS2030(%)FIGURE14.AMERICASGLYCINATESMARKETSIZE,BYCOUNTRY,2023VS2024VS2030(USDMILLION)FIGURE15.UNITEDSTATESGLYCINATESMARKETSIZE,BYSTATE,2023VS2030(%)FIGURE16.UNITEDSTATESGLYCINATESMARKETSIZE,BYSTATE,2023VS2024VS2030(USDMILLION)FIGURE17.ASIA-PACIFICGLYCINATESMARKETSIZE,BYCOUNTRY,2023VS2030(%)FIGURE18.ASIA-PACIFICGLYCINATESMARKETSIZE,BYCOUNTRY,2023VS2024VS2030(USDMILLION)FIGURE19.EUROPE,MIDDLEEAST&AFRICAGLYCINATESMARKETSIZE,BYCOUNTRY,2023VS2030(%)FIGURE20.EUROPE,MIDDLEEAST&AFRICAGLYCINATESMARKETSIZE,BYCOUNTRY,2023VS2024VS2030(USDMILLION)FIGURE21.GLYCINATESMARKETSHARE,BYKEYPLAYER,2023FIGURE22.GLYCINATESMARKET,FPNVPOSITIONINGMATRIX,2023LISTOFTABLESTABLE1.GLYCINATESMARKETSEGMENTATION&COVERAGETABLE2.UNITEDSTATESDOLLAREXCHANGERATE,2018-2023TABLE3.GLOBALGLYCINATESMARKETSIZE,2018-2023(USDMILLION)TABLE4.GLOBALGLYCINATESMARKETSIZE,2024-2030(USDMILLION)TABLE5.GLOBALGLYCINATESMARKETSIZE,BYREGION,2018-2023(USDMILLION)TABLE6.GLOBALGLYCINATESMARKETSIZE,BYREGION,2024-2030(USDMILLION)TABLE7.GLOBALGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE8.GLOBALGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE9.GLOBALGLYCINATESMARKETSIZE,BYDRY,BYREGION,2018-2023(USDMILLION)TABLE10.GLOBALGLYCINATESMARKETSIZE,BYDRY,BYREGION,2024-2030(USDMILLION)TABLE11.GLOBALGLYCINATESMARKETSIZE,BYLIQUID,BYREGION,2018-2023(USDMILLION)TABLE12.GLOBALGLYCINATESMARKETSIZE,BYLIQUID,BYREGION,2024-2030(USDMILLION)TABLE13.GLOBALGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE14.GLOBALGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE15.GLOBALGLYCINATESMARKETSIZE,BYCALCIUMGLYCINATE,BYREGION,2018-2023(USDMILLION)TABLE16.GLOBALGLYCINATESMARKETSIZE,BYCALCIUMGLYCINATE,BYREGION,2024-2030(USDMILLION)TABLE17.GLOBALGLYCINATESMARKETSIZE,BYCOPPERGLYCINATE,BYREGION,2018-2023(USDMILLION)TABLE18.GLOBALGLYCINATESMARKETSIZE,BYCOPPERGLYCINATE,BYREGION,2024-2030(USDMILLION)TABLE19.GLOBALGLYCINATESMARKETSIZE,BYMAGNESIUMGLYCINATE,BYREGION,2018-2023(USDMILLION)TABLE20.GLOBALGLYCINATESMARKETSIZE,BYMAGNESIUMGLYCINATE,BYREGION,2024-2030(USDMILLION)TABLE21.GLOBALGLYCINATESMARKETSIZE,BYMANGANESEGLYCINATE,BYREGION,2018-2023(USDMILLION)TABLE22.GLOBALGLYCINATESMARKETSIZE,BYMANGANESEGLYCINATE,BYREGION,2024-2030(USDMILLION)TABLE23.GLOBALGLYCINATESMARKETSIZE,BYSODIUMGLYCINATE,BYREGION,2018-2023(USDMILLION)TABLE24.GLOBALGLYCINATESMARKETSIZE,BYSODIUMGLYCINATE,BYREGION,2024-2030(USDMILLION)TABLE25.GLOBALGLYCINATESMARKETSIZE,BYZINCGLYCINATE,BYREGION,2018-2023(USDMILLION)TABLE26.GLOBALGLYCINATESMARKETSIZE,BYZINCGLYCINATE,BYREGION,2024-2030(USDMILLION)TABLE27.GLOBALGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2023(USDMILLION)TABLE28.GLOBALGLYCINATESMARKETSIZE,BYAPPLICATION,2024-2030(USDMILLION)TABLE29.GLOBALGLYCINATESMARKETSIZE,BYFEEDADDITIVES,BYREGION,2018-2023(USDMILLION)TABLE30.GLOBALGLYCINATESMARKETSIZE,BYFEEDADDITIVES,BYREGION,2024-2030(USDMILLION)TABLE31.GLOBALGLYCINATESMARKETSIZE,BYFOODADDITIVES,BYREGION,2018-2023(USDMILLION)TABLE32.GLOBALGLYCINATESMARKETSIZE,BYFOODADDITIVES,BYREGION,2024-2030(USDMILLION)TABLE33.GLOBALGLYCINATESMARKETSIZE,BYPERSONALCAREPRODUCTS,BYREGION,2018-2023(USDMILLION)TABLE34.GLOBALGLYCINATESMARKETSIZE,BYPERSONALCAREPRODUCTS,BYREGION,2024-2030(USDMILLION)TABLE35.GLOBALGLYCINATESMARKETSIZE,BYPHARMACEUTICALS&NUTRACEUTICALS,BYREGION,2018-2023(USDMILLION)TABLE36.GLOBALGLYCINATESMARKETSIZE,BYPHARMACEUTICALS&NUTRACEUTICALS,BYREGION,2024-2030(USDMILLION)TABLE37.AMERICASGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE38.AMERICASGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE39.AMERICASGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE40.AMERICASGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE41.AMERICASGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2023(USDMILLION)TABLE42.AMERICASGLYCINATESMARKETSIZE,BYAPPLICATION,2024-2030(USDMILLION)TABLE43.AMERICASGLYCINATESMARKETSIZE,BYCOUNTRY,2018-2023(USDMILLION)TABLE44.AMERICASGLYCINATESMARKETSIZE,BYCOUNTRY,2024-2030(USDMILLION)TABLE45.ARGENTINAGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE46.ARGENTINAGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE47.ARGENTINAGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE48.ARGENTINAGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE49.ARGENTINAGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2023(USDMILLION)TABLE50.ARGENTINAGLYCINATESMARKETSIZE,BYAPPLICATION,2024-2030(USDMILLION)TABLE51.BRAZILGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE52.BRAZILGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE53.BRAZILGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE54.BRAZILGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE55.BRAZILGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2023(USDMILLION)TABLE56.BRAZILGLYCINATESMARKETSIZE,BYAPPLICATION,2024-2030(USDMILLION)TABLE57.CANADAGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE58.CANADAGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE59.CANADAGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE60.CANADAGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE61.CANADAGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2023(USDMILLION)TABLE62.CANADAGLYCINATESMARKETSIZE,BYAPPLICATION,2024-2030(USDMILLION)TABLE63.MEXICOGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE64.MEXICOGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE65.MEXICOGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE66.MEXICOGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE67.MEXICOGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2023(USDMILLION)TABLE68.MEXICOGLYCINATESMARKETSIZE,BYAPPLICATION,2024-2030(USDMILLION)TABLE69.UNITEDSTATESGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE70.UNITEDSTATESGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE71.UNITEDSTATESGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE72.UNITEDSTATESGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE73.UNITEDSTATESGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2023(USDMILLION)TABLE74.UNITEDSTATESGLYCINATESMARKETSIZE,BYAPPLICATION,2024-2030(USDMILLION)TABLE75.UNITEDSTATESGLYCINATESMARKETSIZE,BYSTATE,2018-2023(USDMILLION)TABLE76.UNITEDSTATESGLYCINATESMARKETSIZE,BYSTATE,2024-2030(USDMILLION)TABLE77.ASIA-PACIFICGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE78.ASIA-PACIFICGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE79.ASIA-PACIFICGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE80.ASIA-PACIFICGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE81.ASIA-PACIFICGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2023(USDMILLION)TABLE82.ASIA-PACIFICGLYCINATESMARKETSIZE,BYAPPLICATION,2024-2030(USDMILLION)TABLE83.ASIA-PACIFICGLYCINATESMARKETSIZE,BYCOUNTRY,2018-2023(USDMILLION)TABLE84.ASIA-PACIFICGLYCINATESMARKETSIZE,BYCOUNTRY,2024-2030(USDMILLION)TABLE85.AUSTRALIAGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE86.AUSTRALIAGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE87.AUSTRALIAGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE88.AUSTRALIAGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE89.AUSTRALIAGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2023(USDMILLION)TABLE90.AUSTRALIAGLYCINATESMARKETSIZE,BYAPPLICATION,2024-2030(USDMILLION)TABLE91.CHINAGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE92.CHINAGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE93.CHINAGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE94.CHINAGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE95.CHINAGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2023(USDMILLION)TABLE96.CHINAGLYCINATESMARKETSIZE,BYAPPLICATION,2024-2030(USDMILLION)TABLE97.INDIAGLYCINATESMARKETSIZE,BYFORM,2018-2023(USDMILLION)TABLE98.INDIAGLYCINATESMARKETSIZE,BYFORM,2024-2030(USDMILLION)TABLE99.INDIAGLYCINATESMARKETSIZE,BYTYPE,2018-2023(USDMILLION)TABLE100.INDIAGLYCINATESMARKETSIZE,BYTYPE,2024-2030(USDMILLION)TABLE101.INDIAGLYCINATESMARKETSIZE,BYAPPLICATION,2018-2